What Happened
A new study projects the Indian Ayush services sector to grow substantially, reaching between USD 216-318 billion by 2047. This growth is underpinned by a strong 16.91% CAGR since 2022-23, with Ayurveda and medical value travel being key drivers. This indicates a significant expansion in traditional Indian healthcare and wellness.
Why It Matters (for you)
This projection highlights a massive long-term growth opportunity within India's healthcare landscape, shifting focus towards traditional and holistic wellness. For investors, it signals a burgeoning market segment that could attract increased capital, foster innovation, and create new revenue streams for companies aligned with Ayush principles, including those in FMCG, pharmaceuticals, and healthcare services.
Impact on Indian Markets
Companies with a strong presence in Ayurvedic products and services, such as DABUR and EMAMILTD, are likely to see positive sentiment and potential for sustained revenue growth. Healthcare providers and those involved in medical tourism could also benefit from the 'Medical Value Travel' aspect. The overall healthcare and wellness sector in India stands to gain from this expanding market.
What Traders Should Watch Next
Traders should monitor government policies and initiatives supporting the Ayush sector, new product launches by key players, and quarterly results of companies with significant Ayush exposure.
Key Evidence
- Ayush services sector projected to reach USD 216-318 billion by 2047.
- Sector reported a 16.91 percent compound annual growth rate since 2022-23.
- Supported 1.76 million livelihoods.
- Clinics and day-care centers generated the majority of revenue, with Ayurveda leading individual systems.
- Sector's role in Medical Value Travel is notable, with international patients contributing substantially.